<?xml version="1.0" encoding="utf-8" standalone="no"?>
<?xml-stylesheet type='text/xsl' href='/oai-pmh/oai2.xsl'?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns="http://www.openarchives.org/OAI/2.0/">
  <responseDate>2026-10-13</responseDate>
  <request verb="GetRecord" identifier="oai:researchdata.se:doi-10-17044-scilifelab-31316779/0" metadataPrefix="oai_dc">https://api.researchdata.se/oai-pmh</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:researchdata.se:doi-10-17044-scilifelab-31316779/0</identifier>
        <datestamp>2026-02-13</datestamp>
        <setSpec>subject:ssif:3</setSpec>
        <setSpec>subject:ssif:10605</setSpec>
        <setSpec>subject:ssif:106</setSpec>
        <setSpec>subject:ssif:1</setSpec>
        <setSpec>principal:slug:uppsala-university</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:type>info:eu-repo/semantics/other</dc:type>
          <dc:type>http://purl.org/dc/dcmitype/Dataset</dc:type>
          <dc:identifier>https://doi.org/10.17044/SCILIFELAB.31316779</dc:identifier>
          <dc:title xml:lang="en">Data: Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection (PASC)</dc:title>
          <dc:creator>https://orcid.org/0000-0003-4185-7409</dc:creator>
          <dc:creator>Serena Fineschi</dc:creator>
          <dc:creator>Niklas Dahl</dc:creator>
          <dc:subject xml:lang="en">Medical and Health Sciences</dc:subject>
          <dc:subject xml:lang="sv">Medicin och hälsovetenskap</dc:subject>
          <dc:subject xml:lang="en">Immunology</dc:subject>
          <dc:subject xml:lang="sv">Immunologi</dc:subject>
          <dc:description xml:lang="en">Plasma proteomic profiling of 92 individuals with Post-Acute Sequelae of SARS-CoV-2 infection (PASC), assessed a mean of 34 months after acute infection, revealed a distinct inflammatory signature. Using proximity extension assay technology, 358 proteins were quantified, identifying 26 differentially expressed proteins (DEPs) in PASC: 23 upregulated and 3 downregulated. The most upregulated proteins were Oncostatin M (OSM) and IL-1 receptor antagonist (IL1RN). Additional increases were observed in IL-6, IL-12B, IL-2, CCL22, CSF3, CSF1, and HLA-DRA, as well as proteins involved in tissue remodeling and angiogenesis such as ANGPTL2 and TGFA. Random forest analysis confirmed IL1RN, OSM, ANGPTL2, HLA-DRA, and CLEC4A as strong discriminators between patients and controls. Gene set enrichment analysis demonstrated activation of multiple immune pathways, including Inflammatory Response, TNF-α/NF-κB signaling, IL-6/JAK/STAT3, IL-2/STAT5, and Allograft Rejection, indicating persistent activation of innate and adaptive immunity. STRING network analysis highlighted a tightly connected cytokine-driven inflammatory module. Plasma spike protein levels did not differ between patients and controls, suggesting that PASC-related inflammation may persist independently of ongoing viral replication. Overall, the findings indicate a consistent low-grade inflammatory state in PASC without evidence for distinct biological subtypes.</dc:description>
          <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
          <dc:publisher xml:lang="en">Uppsala University</dc:publisher>
          <dc:publisher xml:lang="sv">Uppsala universitet</dc:publisher>
          <dc:date>2026-02-13T00:00:00Z</dc:date>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>